| ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More | Ben Fidler | 10/01/19 | National |
| Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More | Frank Vinluan | 09/27/19 | National |
| Report: IPO Activity Picking Back Up Following Quiet, Volatile Q3 | Sarah de Crescenzo | 09/25/19 | San Diego |
| Bio Roundup: Pelosi’s Reveal, Alder’s Deal, Biogen’s Fails & More | Alex Lash | 09/20/19 | National |
| Amazon Sets Electric Vehicle, Carbon Footprint Goals Amid Criticism | Jeff Buchanan | 09/19/19 | Seattle |
| Pelosi, Dems Unveil Price Plan: Are 25 Drugs Enough for Negotiation? | Alex Lash | 09/19/19 | National |
| Why Menlo Ventures Backed Construction Tech Firm Fieldwire | Bernadette Tansey | 09/16/19 | San Francisco |
| After First Look at House Drug Plan, Stocks Rise Slightly | Alex Lash | 09/10/19 | National |
| Herceptin Inventors, Immunology Pioneers Take Home 2019 Lasker Awards | Ben Fidler | 09/10/19 | National |
| At Big Lung Cancer Meeting, Lights Shine on KRAS, Drug Combos & More | Ben Fidler | 09/09/19 | National |
| Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone | Frank Vinluan | 09/06/19 | National |
| With FDA’s Eye on JAK Drugs, Concert Moves One Ahead For Hair Loss | Ben Fidler | 09/03/19 | Boston |
| Robocalls Crowd Out Real Business Calls. This Startup Has an Answer. | David Holley | 08/30/19 | Seattle |
| Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More | Alex Lash | 08/30/19 | National |
| $5.8B for Nothing: AbbVie Shelves Stemcentrx Drug After Latest Flop | Ben Fidler | 08/29/19 | Detroit Ann Arbor |
| ThoughtSpot Nabs $248M for Accessible Analytics, Nears $2B Valuation | Bernadette Tansey | 08/28/19 | San Francisco |
| New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.) | Alex Lash | 08/26/19 | National |
| Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More | Frank Vinluan | 08/23/19 | National |
| Ford’s Autonomic Connects EV Maker Ayro to Its Mobility Cloud | Bernadette Tansey | 08/21/19 | San Francisco |
| Elanco’s $7.6B Deal With Bayer Bolsters Pets, Farm Animals Footprint | Frank Vinluan | 08/20/19 | Indiana |
| Bio Roundup: Zolgensma Fallout, Duchenne Redux, Ebola Boost & More | Alex Lash | 08/16/19 | National |
| Will Porsche Fans Ever Live in a Driverless World? Porsche Says No. | Bernadette Tansey | 08/16/19 | San Francisco |
| Four New Drugs Are Around the Corner. Here’s What You Need to Know. | Ben Fidler | 08/15/19 | National |
| Mason Raises $25M to Help Software Firms Deploy, Manage Applications | Jeff Buchanan | 08/14/19 | Seattle |
| Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More | Frank Vinluan | 08/02/19 | National |
| Ford, Retreating From Bold Timeline, Buys Quantum Signal for AV Tech | Bernadette Tansey | 08/01/19 | San Francisco |
| Amicus Offers First Look At Gene Therapy Work With Batten’s Data | Ben Fidler | 08/01/19 | New York |
| White House Floats Canadian Import Plan But Excludes Many Costly Drugs | Frank Vinluan | 07/31/19 | National |
| Mark Levin Named Xconomy’s 2019 Lifetime Achievement Award Winner in Boston | Angela Shah | 07/31/19 | National |
| Duchenne Advocates Start Casimir, Aiming to Capture Missing Data | Ben Fidler | 07/26/19 | Boston |
